B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Although the research has so far only been conducted in cell lines and mice, the team is seeking funding ... It turned out to be far more serious – Gill would be diagnosed with B-cell acute ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

The cells are multiplied outside the patients' bodies and then administered to them. The therapy is already in practical use for patients of acute lymphocytic leukemia and malignant lymphoma.